Predictors of Augmented Renal Clearance in a Heterogeneous ICU Population as Defined by Creatinine and Cystatin C

Andrea M. Nei,Kianoush B. Kashani,Ross Dierkhising,Erin F. Barreto
DOI: https://doi.org/10.1159/000507255
2020-01-01
Nephron
Abstract:<span><b><i>Introduction:</i></b> The incidence of augmented renal clearance (ARC) in the intensive care unit (ICU) is highly variable, and identification of these patients remains challenging. <b><i>Objective:</i></b> The objective of this study was to define the incidence of ARC in a cohort of critically ill adults, using serum Cr and cystatin C, and to identify factors associated with its development. <b><i>Methods:</i></b> This is a retrospective cohort study of critically ill patients without stage 2 or 3 acute kidney injury with both serum Cr and cystatin C available. The incidence of ARC was defined as a Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI)<sub>Cr-cystatin C</sub>-estimated glomerular filtration rate #x3e;130 mL/min. A multivariable logistic regression model using a penalized Lasso method was fit to identify independent predictors of ARC. <b><i>Results:</i></b> Among the 368 patients included in the study, indication for ICU admission was nonoperative in 55% of patients, and 9% of patients were admitted for major trauma. The overall incidence of ARC was low at 4.1%. In a multivariable logistic regression model, Charlson comorbidity index, major trauma, intracerebral hemorrhage, age, and Sequential Organ Failure Assessment score were found to predict ARC. <b><i>Conclusion:</i></b> The incidence of ARC in this study was low, but prediction models identified several factors for early identification of patients with risk factors for or who develop ARC, particularly in a cohort with a low baseline risk of ARC. These factors could be used to help identify patients who may develop ARC. <br/>Nephron</span>
urology & nephrology
What problem does this paper attempt to address?